Oncogene products and other diagnostic markers in human breast cancer patients. Treatment effects and their significance.
Dowsett
M
M
Academic Department of Biochemistry, Royal Marsden Hospital, London, England.
Makris
A
A
Ellis
P
P
Johnston
S R
SR
Salter
J
J
Detre
S
S
Humphries
S
S
Saccani-Jotti
G
G
Powles
T J
TJ
Smith
I E
IE
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins / Q000032:analysis; D015513:Oncogene Proteins / Q000032:analysis*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D011960:Receptors, Estrogen; D013629:Tamoxifen